Drugs known to influence gastrointestinal symptoms—including GERD therapies, prokinetics, anticholinergics, alpha-glucosidase inhibitors, and osmotic laxatives—could therefore not be adjusted for in our analyses. Here, GAA is linked to gastroesophageal reflux disease.